Exone Co (XONE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XONE Annual Balance Sheets →
This page allows investors to track Exone Co's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2021)
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Assets
Cash & cash equivalent122.81
Cash & Short-term Investments122.00
Accounts receivable8.71
Inventories25.08
Other Current Assets2.11
Prepaid Expense And Other Assets Current6.31
Total Current Assets165.02
Equipment/Property/Plant Net22.82
Other Assets, Noncurrent3.50
Restricted Cash Current1.87
Net Investment In Lease Current0.24
Net Investment In Lease Noncurrent0.33
Total Assets191.34
Liabilities
Accounts Payable, Current AC7.66
Accrued Liabilities, Current AC6.77
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current18.66
Total Current Liabilities33.08
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.92
Contract With Customer Liability Current16.73
Contract With Customer Liability Noncurrent0.03
Total Liabilities34.00
Stockholders' Equity
Common Stock Value0.22
Additional Paid In Capital Common Stock317.11
Retained Earnings / Accumulated Deficit-148.49
Other Equity-11.50
Common Stockholder's Equity157.34
Total Stockholder's Equity157.34
Liabilities & Stockholder's Equity191.34
4 historic quarters locked

Sign in to unlock the full Exone Co balance sheet history.

About XONE Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.